INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 38 filers reported holding INFLARX NV in Q2 2020. The put-call ratio across all filers is 6.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $149,000 | -33.2% | 50,000 | 0.0% | 0.13% | -24.0% |
Q2 2023 | $223,000 | +163870.6% | 50,000 | -28.6% | 0.17% | +57.5% |
Q1 2023 | $136 | -37.3% | 70,000 | 0.0% | 0.11% | -30.7% |
Q4 2022 | $217 | -99.9% | 70,000 | 0.0% | 0.15% | +17.7% |
Q3 2022 | $185,000 | +81.4% | 70,000 | 0.0% | 0.13% | +75.7% |
Q2 2022 | $102,000 | -20.3% | 70,000 | 0.0% | 0.07% | -19.6% |
Q1 2022 | $128,000 | -61.6% | 70,000 | 0.0% | 0.09% | -57.2% |
Q4 2021 | $333,000 | +84.0% | 70,000 | 0.0% | 0.22% | +74.8% |
Q3 2021 | $181,000 | -13.0% | 70,000 | 0.0% | 0.12% | -0.8% |
Q2 2021 | $208,000 | -23.8% | 70,000 | 0.0% | 0.12% | -23.5% |
Q1 2021 | $273,000 | -22.4% | 70,000 | 0.0% | 0.16% | -20.2% |
Q4 2020 | $352,000 | -40.9% | 70,000 | -50.0% | 0.20% | +2.0% |
Q3 2020 | $596,000 | +85.7% | 140,000 | +100.0% | 0.20% | +2.6% |
Q2 2020 | $321,000 | -23.6% | 70,000 | -36.4% | 0.19% | -48.0% |
Q1 2020 | $420,000 | -30.6% | 110,000 | +587.5% | 0.37% | -1.6% |
Q1 2019 | $605,000 | +4.0% | 16,000 | 0.0% | 0.38% | -31.2% |
Q4 2018 | $582,000 | +6.0% | 16,000 | 0.0% | 0.55% | +55.6% |
Q3 2018 | $549,000 | +6.4% | 16,000 | 0.0% | 0.35% | +0.9% |
Q2 2018 | $516,000 | – | 16,000 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |